CClinicalTrials.gg
RecruitingNCT02010866Updated Apr 30, 2024

Reaching Out to Distressed Medical Residents, Fellows and Faculty

An interventional study of counseling in Depression and Suicide, sponsored by Oregon Health and Science University. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-04-30.

Sponsored by Oregon Health and Science University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Jan 2014; still recruiting 12 years 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
4,000
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to study whether distressed medical residents, fellows, and faculty health professionals benefit from completing online an anonymous and interactive screening of stress, depression, substance use, and suicidal thoughts. The screening and ability to interact online with a clinician anonymously are hypothesized to increase willingness to come for counseling in person. Suicide risk factors are expected to be lower once the distressed medical trainee or faculty member receives treatment.

Read the detailed description

According to theories such as motivational interviewing and stages of change, individuals change health behaviors when the benefits (e.g., being less stressed) outweigh the risks (e.g., concerns about confidentiality of treatment). Prior research suggests that educational programming to promote the benefits and counter the perceived risks of counseling increases adults' motivation to get professional help. Distressed physicians' motivation to seek help following an educational intervention has not been evaluated but organizations such as the American Foundation for Suicide Prevention, Association for the Accreditation of Graduate Medical Education, and the American Medical Association have developed policies and programming to educate physicians about the importance of treating depression and reducing suicide risk in themselves and their colleagues.

A "best practices" suicide prevention program in 50+ US universities, the American Foundation for Suicide Prevention's Interactive Screening Program (ISP), was identified by the Oregon Health and Science University (OHSU) Resident and Faculty Wellness Program (RFWP) clinicians as a possible avenue by which to reach distressed OHSU trainees and faculty and encourage them to get help. The "Stress and Depression Questionnaire" is an anonymous, online screening tool for stress, depression, substance abuse, eating disorders, and suicide risk. Responses are scored and ranked according to level of distress and risk with Tier 1 representing "high risk, high distress" and Tier 2 "moderate distress, less risk" and Tier 3 "low or no distress or risk". RFWP clinicians will monitor responses, provide prompt communication back to the participants with information about how they scored, resources available to them, address any questions/concerns they might have and invite them to set up an appointment at the RFWP (if distressed). Moutier and her colleagues at a similar size academic medical center to OHSU, University of California at San Diego (UCSD), administered this survey to all medical students, residents, fellows, and faculty (13% completed it) and the majority eventually seen by clinicians indicated that they never would have sought help if they had not received feedback on the ISP and been encouraged to come in for evaluation/treatment. Being able to anonymously dialogue with a clinician about their specific situation and questions appeared to persuade some participants to come in for an evaluation or accept a referral. This academic medical center did not have an in-house counseling program for residents and faculty like the OHSU RFWP-UCSD trainees received an initial evaluation from a clinician and then were provided with community referrals. Their participation rate of 13% is similar to rates of participation in the ISP in undergraduate populations. In the present study, it is hypothesized that a highly visible and utilized RFWP may lead to a higher ISP participation rate among the residents, fellows, and faculty.

Although the ultimate goal is to save lives (i.e., reduce the rate of suicide among medical trainees and faculty), the low base rate of suicide in a population makes it difficult to evaluate whether the implementation of the ISP at OHSU will lead to a drop in suicide rates at this institution. Even using patient suicidal ideation and attempts as outcomes is problematic as this information can be difficult to gather unless the patient is actively involved in treatment at the time. Rather in the present study the effectiveness of this suicide prevention program will be measured by examining related variables to suicide risk-increases in protective factors and decreases in risk factors. Specifically, these researchers seek to decrease known risk factors (e.g., identify and intervene with untreated depression, substance abuse, high level of stress) and increase protective factors (e.g., promote self-awareness, receipt of support and resources and delivery of mental health services if needed).

Present study aims are to:

  • reduce known risk factors of untreated psychological distress (e.g., depression, high stress level, substance abuse) by encouraging all residents, fellows, and School of Medicine (SOM) faculty to complete a self-assessment of their level of stress and risk using the ISP and then offer professional help through a personalized message/dialogue that directly addresses any concerns/barriers about seeking help at the RFWP and offers resources for better coping;
  • increase self-awareness in mildly/moderately distressed trainees and faculty who fill out the ISP and offer preventive/early intervention educational resources via the ISP on topics that are relevant to them (based on their responses);
  • evaluate whether all RFWP patients (ones who come to the program via ISP and other referral sources) report decreased psychological distress, burnout, and risk of suicide across treatment;
  • assess levels of distress and flourishing among RFWP participants over time
  • assess level of satisfaction with the RFWP educational outreach workshops, consultation to department leaders (and referral of their trainees and/or faculty), and clinical services provided to distressed trainees and faculty.
02

Conditions studied

  • Depression
  • Suicide

Keywords

  • internship and residency
  • physicians
  • prevention
  • counseling
  • suicide
  • depression
  • burnout
03

In context

Depression

8,057 studies on the registry are indexed under Depression; 1,641 are open to participants now.

This study's planned enrollment of 4,000 is above the median of 84 across 6,720 interventional studies indexed under Depression.

Browse Depression studies →

Lead sponsor

Oregon Health and Science University is the lead sponsor of 676 studies on the registry; 136 are open to participants now.

Of its 49 completed or terminated interventional studies of FDA-regulated products, 36 (73%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • OHSU medical residents, fellows, and full-time School of Medicine faculty

Exclusion criteria

Exclusion Criteria:

  • individuals not meeting the above inclusion criteria
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
4,000 participants (estimated)

Study arms

  • Other
    Counseling

    in-person counseling through RFWP to distressed respondents on the ISP and patients who seek counseling without completing the ISP

    Behavioral: counseling

Interventions

  • Behavioralcounseling

    in-person counseling through RFWP offered to distressed respondents on the ISP and others who seek counseling (due to other reasons for referral)

06

What researchers measure

Primary outcomes

  1. ISP levels of distress seen with medical trainees and faculty

    online, anonymous Interactive Screening Program (ISP) measures stress, depression, anxiety, substance abuse, and suicidal ideation--participants fill out survey at different points and may or may not come in for counseling

    Time frame: Time survey is completed by trainee or faculty member at baseline

  2. Demographics of residents and faculty physicians who seek counseling through in house program

    Demographics of residents, faculty at time of intake for counseling at Resident and Faculty Wellness Program

    Time frame: at enrollment for treatment (intake appointment)

  3. Who responds to treatment--level of distress

    % of participants in counseling services through Resident and Faculty Wellness who show change in psychological distress on ACORN from baseline to end of treatment

    Time frame: time of intake (baseline) to participants' end of treatment or 6 months since last seen

  4. Who responds to treatment-level of burnout

    participants at Resident and Faculty Wellness Program who show significant decline in burnout on MBI screening items (emotional exhaustion and depersonalization items) from baseline (time of intake) to end of treatment

    Time frame: time of intake to participants' end of treatment or 6 months since last seen

  5. Who responds to treatment-clinician rating of suicide risk

    participants of Resident and Faculty Wellness Program who show change in clinician rating of suicide risk during treatment

    Time frame: time of intake (baseline) to participants end of treatment or 6 months since last seen

07

Study locations

1 of 1 sites recruiting
  • Oregon Health and Science University
    Portland, Oregon 97239, United States
    • Liz Stevenson, JD · Contact · steveeli@ohsu.edu · 503-494-6144
    • Marie V Soller, MD · Principal investigator
    Recruiting
08

References and documents

Study documents

  • Study protocol · Apr 27, 2024

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No — will not be sharing data with other researchers outside of this project

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 30, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02010866
Lead sponsor
Oregon Health and Science University
Responsible party
Marie Soller (Professor, Psychiatry, Resident and Faculty Wellness, Oregon Health and Science University) — Principal investigator
First posted
Dec 13, 2013
Start date
Jan 2014
Primary completion
Oct 2030 (estimated)
Completion
Oct 2030 (estimated)
Last update
Apr 30, 2024

Study contacts

Marie V Soller, MD
Contact
soller@ohsu.edu
503-494-9000
Gillian Lashen, Ph.D.
Contact
lashen@ohsu.edu
503-494-9000
Marie V Soller, MD
principal investigator · Oregon Health and Science University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion